ArticleInternational journal of radiation oncology, biology, physics2024

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.

Shrey Ramesh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.